← Browse by Condition
Medical Condition
parkinson 39 s disease
Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for parkinson 39 s disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT07100171 EARLY_Phase 1
Recruiting
Evaluation of GM101 Injection in Patients With Parkinson's Disease
Enrollment
10 pts
Location
China
Sponsor
Genemagic Biosciences Co., Ltd
NCT07115394
Recruiting
EEG Measurements to Capture DBS-induced Electric Potentials
Enrollment
20 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology